A Dream of First-World Drug Quality for Third-World India is Deferred
This article was originally published in The Gold Sheet
He prevented his employer from selling substandard drugs in the US. But could Ranbaxy whistleblower Dinesh Thakur convince India to demand higher quality drugs for its own citizens?
Register for our free email digests: